Seeking Clues to Cencora (COR) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
Cencora (COR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside
Cencora (COR) gets its prior buy rating from 2025 reaffirmed, driven by several strong fundamentals, despite a recent price retreat. The healthcare distributor has a global brand footprint, a key role in serving specific clinical needs, and profitability, despite thin margins. The dividend case is compelling, with proven 10 year growth across many market cycles, and a low payout ratio.
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal
Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care market.
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
Cencora's strong U.S. growth, MSO strategy, and raised outlook support long-term potential, but competition and customer losses remain key risks.
California Public Employees Retirement System Has $184.01 Million Stock Holdings in Cencora, Inc. $COR
California Public Employees Retirement System lowered its stake in Cencora, Inc. (NYSE: COR) by 13.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 588,788 shares of the company's stock after selling 93,334 shares during the quarter. California Public Employees Retirement
Chilton Investment Co. Inc. Purchases New Holdings in Cencora, Inc. $COR
Chilton Investment Co. Inc. acquired a new stake in shares of Cencora, Inc. (NYSE: COR) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,468 shares of the company's stock, valued at approximately $459,000. Other hedge funds and other
Alliancebernstein L.P. Has $278.09 Million Stake in Cencora, Inc. $COR
Alliancebernstein L.P. lowered its position in Cencora, Inc. (NYSE: COR) by 21.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 889,802 shares of the company's stock after selling 244,496 shares during the period. Alliancebernstein L.P. owned 0.46% of Cencora worth
Glenmede Investment Management LP Sells 4,232 Shares of Cencora, Inc. $COR
Glenmede Investment Management LP reduced its stake in Cencora, Inc. (NYSE: COR) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 169,665 shares of the company's stock after selling 4,232 shares during the quarter. Glenmede Investment Management
Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 Transcript
Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 Transcript
Cencora, Inc. (COR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Cencora, Inc. (COR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal
Cencora is set to merge MWI Animal Health with Covetrus in a $3.5B deal, retaining a 34.3% stake as it unlocks capital and targets animal health growth.
